Biochips Market Segmentation:
Type Segment Analysis
The DNA chips segment is predicted to dominate market share over the projected time frame. The segment growth can be attributed to increasing use of DNA chips in several clinical diagnostic tests and research work regarding the detection of numerous disorder., coupled with significant rise in the development of DNA chips in recent years. For instance, in 2021, Roswell Biotechnologies Inc., invented the molecular microchip that can detect an individual's molecule. The technology is expected to revolutionize disease detection, drug development, and health monitoring procedures to great extent. The chip is going to be utilized to improve DNA sequencing.
End-user Segment Analysis
The hospitals and diagnostic center segment will garner a significant share by 2035. The segment growth can be accredited to increasing need for advanced medical facilities, diagnosis technologies, and a growing patient pool. On the other hand, the pharmaceutical segment is projected to witness an impressive CAGR during the forecast period, owing to higher indulgence of pharmaceutical companies in the research and development of biochips and their integration. In addition, these pharmaceutical organizations have also been exploring new heights with the deployment of biochips in the process of novel drug discovery, research, and development of novel biomarkers, and gene expression profiling.
Our in-depth analysis of the global market includes the following segments:
|
By Type |
|
|
By Function |
|
|
By Fabrication Technology |
|
|
By Application |
|
|
By End-User |
|
